Early and Midterm Major Adverse Cardiac Events in Patient With Saphenous Vein Graft Using Direct Stenting or Embolic Protection Device Stenting

BACKGROUND: The treatment of an occluded saphenous vein graft (SVG) with percutaneous coronary intervention may encounter major adverse cardiac events (MACE). MACE rates have been reduced significantly by using the embolic protection device (EPD). OBJECTIVES: The aim of this study was to clarify the...

Descripción completa

Detalles Bibliográficos
Autores principales: Sadr-Ameli, Mohammadali, Mousavi, Hossein, Heidarali, Mona, Maadani, Mohsen, Ghelich, Yones, Ghadrdoost, Behshid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kowsar 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4253743/
https://www.ncbi.nlm.nih.gov/pubmed/25478526
http://dx.doi.org/10.5812/cardiovascmed.13012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4253743/
https://www.ncbi.nlm.nih.gov/pubmed/25478526
http://dx.doi.org/10.5812/cardiovascmed.13012

Ejemplares similares